PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

被引：1
|
作者：
Kumar, Harish [1 ]
Dhir, Aditi [2 ]
Paterson, Andrew J. [3 ]
Anderson, Nick R. [4 ]
Qiu, Shaowei [4 ]
Zhao, Xinyang [5 ]
Lu, Rui [4 ]
Bhatia, Ravi [4 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, UAB, Div Hematol & Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-168326
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3073 / 3074
页数：2
相关论文
共 50 条
  • [1] Role of Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Yan, Chengcheng
    Paterson, Andrew J.
    Li, Hui
    Anderson, Nick
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Yang, Jing
    Xie, Min
    Lu, Rui
    Welner, Rob S.
    Bhatia, Ravi
    BLOOD, 2019, 134
  • [2] The Arginine Methyltransferase PRMT5 Regulates Maintenance and TKI Resistance of Self-Renewing FLT3-ITD AML LSC
    Kumar, Harish
    Mohamed, Mostafa
    Dhir, Aditi
    Burslem, George M.
    Zhao, Xinyang
    Lu, Rui
    Ahn, Erin
    Bhatia, Ravi
    BLOOD, 2024, 144 : 1391 - 1392
  • [3] An Epigenetic Screen Identifies PRMT5 As a Target for Inhibition of FLT3-ITD AML Cell Growth in Combination with Tyrosine Kinase Inhibitors
    Dhir, Aditi
    Paterson, Andrew J.
    Qiu, Shaowei
    Mullen, Amanda K.
    Anderson, Nick R.
    Bhatia, Ravi
    BLOOD, 2019, 134
  • [4] Role of Enhanced Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Paterson, Andrew J.
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Mullen, Amanda K.
    Li, Hui
    Harris, Mason W.
    Anderson, Nicholas R.
    Bhatia, Ravi
    BLOOD, 2018, 132
  • [5] The Anti-Leprosy Agent Clofazimine Inhibits FLT3-ITD Mutant AML Stem Cells and Potently Enhances Effects of TKI
    Kumar, Harish
    Paterson, Andrew J.
    Anderson, Nick R.
    Qiu, Shaowei
    Sanyal, Sabyasachi
    Bhatia, Ravi
    BLOOD, 2022, 140 : 11533 - 11534
  • [6] The AML-Associated FLT3-ITD Kinase Regulates Histone Modifications and Cytokine Signaling, Via Effects on PRMT5
    Ando, Koji
    Hamard, Pierre-Jacques
    Liu, Fan
    Martinez, Concepcion
    Ban, Yuguang
    Chen, Xi
    Nimer, Stephen D.
    BLOOD, 2016, 128 (22)
  • [7] MUTATIONAL PROFILE OF LEUKEMIC STEM CELLS IN FLT3-ITD POSITIVE AML
    Ottone, T.
    Alfonso, V.
    Travaglini, S.
    Angelini, D. F.
    Guerrera, G.
    Lavorgna, S.
    Divona, M.
    Iaccarino, L.
    Consalvo, M. Irno
    Cicconi, L.
    De Bardi, M.
    Neri, B.
    Martini, V.
    Fianchi, L.
    Battistini, L.
    Maurillo, L.
    Buccisano, F.
    Venditti, A.
    Arcese, W.
    Lo Coco, F.
    Voso, M. T.
    HAEMATOLOGICA, 2019, 104 : 13 - 13
  • [8] Mutational Profile of Leukemic Stem Cells in FLT3-ITD Mutated AML
    Ottone, Tiziana
    Travaglini, Serena
    Alfonso, Valentina
    Angelini, Daniela
    Guerrera, Gisella
    Lavorgna, Serena
    Divona, Mariadomenica
    Nardozza, Anna Maria
    Cristiano, Antonio
    Consalvo, Maria Irno
    De Bardi, Marco
    Neri, Benedetta
    Marchesi, Francesco
    Gurnari, Carmelo
    Paterno, Giovangiacinto
    Martini, Vincenza
    Battistini, Luca
    Venditti, Adriano
    Buccisano, Francesco
    Arcese, William
    Lo-Coco, Francesco
    Voso, Maria Teresa
    BLOOD, 2019, 134
  • [9] Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells
    Darici, Salihanur
    Jorgensen, Heather G.
    Huang, Xu
    Serafin, Valentina
    Antolini, Ludovica
    Barozzi, Patrizia
    Luppi, Mario
    Forghieri, Fabio
    Marmiroli, Sandra
    Zavatti, Manuela
    ADVANCES IN BIOLOGICAL REGULATION, 2023, 89
  • [10] DNA-PK INHIBITION SENSITIZES FLT3-ITD AML CELLS TO CYTARABINE AND SORAFENIB
    Murray, Heather
    Al Mazi, Juhura
    Kahl, Richard
    Flanagan, Hayley
    Smith, Nathan
    Enjeti, Anoop
    Larsen, Martin
    Verrills, Nicole
    Dun, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 15 - 16
12345